CDH1 and cancer: E-cadherin downregulation also contributes to tumor metastasis through the activation of signaling pathways that drive EMT, therefore promoting the expression of mesenchymal markers such as N-cadherin, vimentin, and fibronectin, which further enhance the migratory and invasive capabilities of cancer cells [190].